Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids

Journal of Lipid Research

Volumn 42, Issue 9, 2001, Pages 1430-1437

  Marathe, Gopal K ^d   Silva, Adriana Ribeiro ^d   De Castro Faria Neto, Hugo Caire ^d   Tjoelker, Larry W ^c   Prescott, Stephen M ^a,b   Zimmerman, Guy A ^a   McIntyre, Thomas M ^a,e  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

Inflammation; LPC; Neutrophil; PAF receptor

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; CALCIUM ION; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; PHOSPHOLIPID METABOLISM; PLEURISY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; CALCIUM; DRUG CONTAMINATION; FLUORESCENCE; HUMANS; HYDROLYSIS; INFLAMMATION; LYSOPHOSPHATIDYLCHOLINES; MICE; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PLEURISY; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0035652796     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction
2. Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients
3. Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: Effect of lysophosphatidylcholine composition on vascular relaxation
4. Air oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma
5. Human plasma platelet-activating factor acetylhydrolase: Oxidatively-fragmented phospholipids as substrates
6. Regulation of cell growth by oxidized LDL
7. Lysophosphatidylcholine (LPC) induces pro-inflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism
8. Lysophosphatidylcholine induces heparin-binding epidermal growth factor-like growth factor and interferon-gamma in human T-lymphocytes
9. Stereospecific chemoattraction of lymphoblastic cells by gradients of lysophosphatidylcholine
10. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions
11. Lysophosphatidylcholine induces the production of IL-lbeta by human monocytes
12. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
13. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration
14. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
15. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells
16. Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes
17. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate
18. A radioreceptor binding assay for platelet-activating factor (PAF) using membranes from CHO cells expressing human PAF receptor
19. Platelet-activating factor receptor and signal transduction
20. The chemical and biological properties of PAF agonists, antagonists, and biosynthetic inhibitors
21. Platelet-activating factor and related lipid mediators
22. Platelet-activating factor and analogues: Comparative studies with human neutrophils and rabbit platelets
23. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxy groups
24. 2+ signaling via the platelet-activating factor receptor in macrophages
25. Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages
26. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells
27. Mechanism of endothelium-dependent vasorelaxation evoked by lysophosphatidylcholine
28. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig
29. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
30. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density, lipoproteins
31. Inflammatory PAF-like lipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines
32. Oxidized phospholipids are specific, high affinity PPAR-γ ligands and agonists
33. A rapid method of total lipid extraction and purification
34. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro
35. 2+ indicators with greatly improved fluorescence properties
36. Long-lasting inhibitory activity of the hetrazepinic BN 50730 on exudation and cellular alterations evoked by PAF and LPS
37. The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid
38. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2
39. Identification of the first m,o L%vo high affinity receptors for Sphingosylphosphorylcholine (SPC) and the first receptor for Lysophosphatidylcholine (LPC)
40. IFN-g upregulates platelet-activating factor receptor gene expression in human monocytes
41. Induction of functionally active platelet-activating factor receptors in rat alveolar macrophages
42. Oxidatively modified LDL contains phospholipids with PAF-like activity, and stimulates the growth of smooth muscle cells
43. Identification and functional characterization of platelet-activating receptors in human leukocyte populations using polyclonal antipeptide antibody
44. Induction of high-affinity PAF receptor expression during T cell activation
45. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin
46. The vascular distribution of the platelet-activating factor receptor
47. Characterization of the alkyl ether species of phosphatidylcholine in bovine heart
48. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor
49. Lipid peroxidation in low density, lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids
50. Identification of short-chain oxidized phosphatidylcholine in human plasma
51. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis
52. Low density lipoprotein oxidation and its pathobiological significance
53. The role of oxidized lipoproteins in atherogenesis
54. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
55. Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein
56. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase
57. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
58. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL
59. Human plasma platelet-activating factor acetylhydrolase: Association with lipoprotein particles and role in the degradation of platelet-activating factor
60. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta